Medical News

RSS
Watermark Medical completes $15M equity investment from CA Technologies

Watermark Medical completes $15M equity investment from CA Technologies

XCell-Center GmbH announces approval of clinical trial in patients with chronic spinal cord injury

XCell-Center GmbH announces approval of clinical trial in patients with chronic spinal cord injury

Hospira to fund $2M loan to Javelin

Hospira to fund $2M loan to Javelin

Immunome selected as winner of annual New York Venture Summit Top Innovator award

Immunome selected as winner of annual New York Venture Summit Top Innovator award

Preliminary outcomes and trends from Phase III pivotal study of Generex Oral-lyn reported

Preliminary outcomes and trends from Phase III pivotal study of Generex Oral-lyn reported

Elekta Neuromag TRIUX system unveiled at Organization of Human Brain Mapping's Annual Meeting

Elekta Neuromag TRIUX system unveiled at Organization of Human Brain Mapping's Annual Meeting

Promising clinical data on CDX-011 in metastatic melanoma presented at ASCO Annual Meeting

Promising clinical data on CDX-011 in metastatic melanoma presented at ASCO Annual Meeting

Angiochem presents positive Phase 1/2 clinical data of ANG1005 for brain cancer at ASCO 2010

Angiochem presents positive Phase 1/2 clinical data of ANG1005 for brain cancer at ASCO 2010

Alnylam presents interim data from ALN-VSP02 Phase I trial for liver cancer at ASCO 2010

Alnylam presents interim data from ALN-VSP02 Phase I trial for liver cancer at ASCO 2010

BGS develops new bio filters for testing E. coli, salmonella, listeria and pseudomonas in food samples

BGS develops new bio filters for testing E. coli, salmonella, listeria and pseudomonas in food samples

SEMHIE wins $3M contract for Social Security Administration's electronic medical records initiative

SEMHIE wins $3M contract for Social Security Administration's electronic medical records initiative

SponsorFit launches initiative to provide free exercise programs to educators

SponsorFit launches initiative to provide free exercise programs to educators

CryoLife purchases patent involving formulation, use of recombinant human serum albumin and gluteraldehyde

CryoLife purchases patent involving formulation, use of recombinant human serum albumin and gluteraldehyde

Clinical trial data of XP19986, XP13512 to be presented at Associated Professional Sleep Society meeting

Clinical trial data of XP19986, XP13512 to be presented at Associated Professional Sleep Society meeting

Phase 1 study data of Keryx' perifosine for recurrent pediatric solid tumors presented at ASCO

Phase 1 study data of Keryx' perifosine for recurrent pediatric solid tumors presented at ASCO

Clivatuzumab tetraxetan shows promising results in patients with metastatic pancreatic cancer

Clivatuzumab tetraxetan shows promising results in patients with metastatic pancreatic cancer

Elsevier, InfoDesk partner to co-develop federated drug pipeline intelligence solution

Elsevier, InfoDesk partner to co-develop federated drug pipeline intelligence solution

Guardian Home Care Holdings, Cardiocom provide home telehealth technology to patients with chronic illnesses

Guardian Home Care Holdings, Cardiocom provide home telehealth technology to patients with chronic illnesses

University Hospitals of Morecambe Bay NHS Trust implements Lorenzo Regional Care Release 1.9

University Hospitals of Morecambe Bay NHS Trust implements Lorenzo Regional Care Release 1.9

CompuMed, CSHC partner to promote CardioGram and CardioGramKids ECG for school health centers

CompuMed, CSHC partner to promote CardioGram and CardioGramKids ECG for school health centers

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.